Abbott introduces new DRG Invisible Trial System for chronic pain management

Abbott has announced the launch of the new DRG Invisible Trial System, approved by the US Food and Drug Administration (FDA) and received CE Mark in Europe.

People suffering from complex chronic pain conditions can now use the DRG Invisible Trial System to try Abbott’s dorsal root ganglion (DRG) stimulation—it’s clinically proven, non-opioid treatment option for targeted chronic pain management.

Patients who are relieved with DRG therapy can then have Abbott’s Proclaim DRG system implanted, it empowers them to manage their pain with familiar Apple consumer technology.

Know More

👇🏻 Please Share

Leave a Reply

Your email address will not be published. Required fields are marked *

Digital Healthcare

Your Health in Your Hand

e-Prescription impacts e-Pharmacy operations

  Map My Health E-prescription Platform     The latest trading trend is to do business and avoid human interference....

child-friendly medicine – still a dream

child-friendly medicine - still a dream Medicine goofed up has resulted in the death of two infants recently. It was...

Sleep Recommended

you should note that people’s sleep needs vary – depending on age, health and lifestyle. The quality of their bed,...

Good Sleep; That you all need

Sleep Sleep is an unconscious state of mind and body which is characterized by muscle relaxation and reduced perception of...

Vaccines: A threat to health Myth or Fact

The measles was declared eliminated from the USA in 2000 but recent news headlines like "Measles making a strong come...